EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual ReportEpigenomics AG publishes financial results for fiscal year 2023 14.03.2024 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2023 Berlin (Germany), March 14, 2024 – Epigenomics AG (FSE: ECX, the “Company”) today reported financial […]
Category: Press Releases
15. February 2024
Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet 15.02.2024 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet Berlin, February 15, 2024 – Epigenomics AG (Frankfurt General […]
31. January 2024
Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board 31.01.2024 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board Berlin, January 31, […]
26. January 2024
Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD)
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) 26.01.2024 / 13:16 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) Berlin, Germany, January 26, 2024 – Dr Heikki Lanckriet (PhD) has informed the competent bodies of Epigenomics AG […]
10. October 2023
Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company’s Assets and Adjustment of Guidance for 2023
EQS-News: Epigenomics AG / Key word(s): Contract/DisposalEpigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company's Assets and Adjustment of Guidance for 2023 10.10.2023 / 21:10 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of […]
05. September 2023
Epigenomics AG: Pareto and Warburg publish analyst research reports
EQS-News: Epigenomics AG / Key word(s): Research UpdateEpigenomics AG: Pareto and Warburg publish analyst research reports 05.09.2023 / 17:20 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Pareto and Warburg publish analyst research reports Analysts consider acceptance of New Day Diagnostics’ purchase offer advantageous for shareholders Buy recommendation with price […]